Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02024685 · ClinicalTrials.gov registry record · NA
Treatment Decision Analysis Model for Prostate Cancer: A Randomized Trial
A NA study, sponsored by Case Comprehensive Cancer Center.
- Terminated
- Registry status
- NA
- Development phase
- 76
- Enrollment target
NCT02024685: Clinical Trial NA study, sponsored by Case Comprehensive Cancer Center.
NCT02024685 is a NA study that was terminated before completion, run by Case Comprehensive Cancer Center. The registered enrollment target is 76 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02024685, a NA study, was terminated before completion, sponsored by Case Comprehensive Cancer Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 76 participants
- Enrollment target
Study Summary
This is a psychosocial/behavioral study and does not involve administration of any treatment or diagnostic procedures. We will use a randomized trial to test the hypothesis that a decision analysis model that provides individualized estimates of quality-adjusted disease-free survival for each of the treatment options for clinically localized prostate cancer will lead to higher quality treatment decisions congruent with a patient's values leading to improved decisional regret and treatment satisfaction. In this trial, all patients would be evaluated at baseline for their utilities for various clinically important health states. The control arm will receive counseling regarding treatment options using standard patient-physician interactions and nomogram-predicted probabilities of treatment outcome for the various treatment options and they will be unaware of the decision analysis recommendation. The treatment arm would be counseled using standard patient-physician interactions and they would also be provided with a personalized treatment recommendations based on the decision analysis model prior to treatment selection. The primary endpoint of this study will be regret-free survival at 2 years after treatment. There will be a 1:1 randomization. A random permuted design will be used to assure approximate balanced number of patients in the two groups over time.
Primary Outcome
To see if a decision analysis model that considers individualized predictions of cancer outcome, treatment-related morbidity, and patient-specific values for clinically important health states leads to higher quality treatment decisions patients will take a validated four item questionnaire which is standardized to a 0-100 point scale where higher values indicate less decisional regret. Scores will be compared between study arms.
Interventions
- BEHAVIORAL Personalized Treatment Recommendations
- BEHAVIORAL Standard patient-physician counseling interaction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2013-08 |
| Est. Completion | 2014-05 |
| Phase | NA |
Why NCT02024685 stopped before completion
NCT02024685 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 76 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Personalized Treatment Recommendations is the first listed.
NCT02024685 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02024685 about?
NCT02024685 is a clinical study titled "Treatment Decision Analysis Model for Prostate Cancer: A Randomized Trial". This is a psychosocial/behavioral study and does not involve administration of any treatment or diagnostic procedures. We will use a randomized trial to test the hypothesis that a decision analysis model that provides individualized estimates of quality-adjusted disease-free survival for each of the...
What is the current status of trial NCT02024685?
This trial is currently terminated. It is a NA study. The enrollment target is 76 participants. The study started on 2013-08. Estimated completion is 2014-05.
What interventions are being tested in trial NCT02024685?
The interventions under investigation include: Personalized Treatment Recommendations (BEHAVIORAL), Standard patient-physician counseling interaction (BEHAVIORAL).
Who is sponsoring clinical trial NCT02024685?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02024685's enrollment target sits among peer trials
76 1062nd of 2000 higher than 932 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02615184 · 76 participants · Phase 2
A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old
- NCT02821741 · 76 participants · NA
Effects of External Ear Stimulation on Pain Perception and Mood
- NCT03019757 · 76 participants
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
- NCT03353584 · 76 participants · NA
Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia